Analyst Research

Report Title Price
Provider: Wright Reports
$75.00
Provider: Reuters Investment Profile
$20.00
Provider: GlobalData
$125.00
Provider: GlobalData
$125.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Biotage AB Issues Financial Goals for Period Between FY 2013 and FY 2015


Thursday, 4 Apr 2013 03:00am EDT 

Biotage AB announced that it has determined the financial goals for the three-year period between fiscal year 2013 and fiscal year 2015, as an average for the period. The Company’s goal is to achieve an average organic growth of 8%. To achieve this goal, the Company needs to succeed in addressing a broader customer base while also broadening its product offering. The ongoing efforts within analytical chemistry and Industrial Resins are examples of this. The Company’s goal is also to achieve an average growth margin of 60%. The Company’s goal is to achieve an average EBIT of 10%. This target is to an extent influenced by the outcome from the Company’s efforts in achieving the growth and EBIT targets. Biotage will continue its efforts to optimize the business operations, while at the same time reducing costs. Amongst other measures there is an ambition to lower the administration and sales costs in relation to sales. 

Company Quote

11.5
0.15 +1.32%
4:00am EDT